Facebook Twitter LinkedIn Google Plus RSS

Bayer announces $1.1B merger with Conceptus

By ,

Wayne-based Bayer HealthCare LLC announced today it will acquire Conceptus Inc., the Mountain View, Calif.-based developer of the Essure procedure, as it broadens its portfolio in contraception.

According to the announcement, Essure is a leading non-surgical permanent birth control method.

Within the next 10 business days, Bayer will launch a public tender offer to acquire all shares in Conceptus, at a rate of $31 per share in cash. Closing is subject to customary conditions, and is expected by mid-year 2013.

According to the announcement, Conceptus generated net sales of $141 million in fiscal 2012.

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!